Publication	Data		Fish	Anatomy
Germano et al., 2022	Fig. 4		gata1am651/m651	blood island mllt3 expression decreased amount, abnormal
Li et al., 2020	Fig. 5		TU + MO1-gata1a	nucleate erythrocyte hbae1.1 expression increased distribution, abnormal
Duchemin et al., 2019	Figure 6		gata1am651/m651	blood viscosity, abnormal ventriculo bulbo valve malformed, abnormal
Lian et al., 2018	Fig. 4		gata1am651/m651; sd2Tg	whole organism heme absent, abnormal
Peters et al., 2018	Fig. 5		gata1am651/m651	blood hemgn expression absent, abnormal brain hemgn expression absent, abnormal
Chen et al., 2017	Fig. 2		s843Tg; uto5Tg + MO1-gata1a	dorsal aorta anatomical region mCherry expression absent, abnormal dorsal aorta vascular associated smooth muscle cell decreased amount, abnormal dorsal aorta vascular associated smooth muscle cell mCherry expression absent, abnormal nucleate erythrocyte absent, abnormal
	Fig. 4		s843Tg + MO1-gata1a	endothelial cell her9 expression decreased amount, abnormal endothelial cell hey1 expression decreased amount, abnormal endothelial cell hey2 expression decreased amount, abnormal endothelial cell jag1b expression decreased amount, abnormal endothelial cell notch1b expression decreased amount, abnormal
	Fig. 6		hu10049Tg + MO1-gata1a ,   WT + MO1-gata1a	dorsal aorta foxc1b expression decreased amount, abnormal whole organism foxc1a expression decreased amount, abnormal whole organism foxc1b expression decreased amount, abnormal
Goddard et al., 2017	Fig. 7		gata1am651/m651	atrioventricular valve wnt9b expression absent, abnormal bulbus arteriosus wnt9b expression absent, abnormal
Holowiecki et al., 2017	Fig. 6		TL + MO1-gata1a	caudal hematopoietic tissue blvra expression increased amount, abnormal caudal hematopoietic tissue blvrb expression increased amount, abnormal heart blvrb expression increased amount, abnormal intermediate cell mass of mesoderm blvra expression decreased amount, abnormal intermediate cell mass of mesoderm blvrb expression absent, abnormal liver blvrb expression increased amount, abnormal
Steed et al., 2016	Fig. 5		ubs10Tg + MO1-gata1a	atrioventricular canal ab2-fn labeling increased amount, abnormal
Heckel et al., 2015	Fig. 2		ubs10Tg + MO1-gata1a ,   ig11Tg + MO1-gata1a ,   sd2Tg + MO1-gata1a	atrial endocardium endothelial cell increased amount, abnormal atrioventricular canal blood circulation process quality, abnormal cardiac ventricle EGFP expression increased amount, abnormal
Takeuchi et al., 2015	Fig. 2		AB + MO1-gata1a	blood island spi1b expression mislocalised, abnormal
	Fig. 4		AB + MO1-gata1a	intermediate cell mass of mesoderm spi1b expression mislocalised, abnormal
	Fig. S2		gata1am651/m651	erythrocyte differentiation decreased process quality, abnormal
Pimtong et al., 2014	Fig. 6		AB + MO1-gata1a	erythroid lineage cell slc4a1a expression decreased amount, abnormal hematopoietic system drl expression decreased amount, abnormal hematopoietic system drll.1 expression decreased amount, abnormal hematopoietic system drll.2 expression decreased amount, abnormal hematopoietic system drll.3 expression decreased amount, abnormal intermediate cell mass of mesoderm drl expression decreased amount, abnormal intermediate cell mass of mesoderm drll.1 expression decreased amount, abnormal intermediate cell mass of mesoderm drll.2 expression decreased amount, abnormal intermediate cell mass of mesoderm drll.3 expression decreased amount, abnormal intermediate cell mass of mesoderm slc4a1a expression decreased amount, abnormal intermediate cell mass of mesoderm spi1b expression increased amount, abnormal monocyte lcp1 expression increased amount, abnormal
Helker et al., 2013	Fig. 8		WT + MO1-gata1a	common cardinal vein blood vessel endothelial cell decreased amount, abnormal nucleate erythrocyte absent, abnormal nucleate erythrocyte development disrupted, abnormal
Belele et al., 2009	Fig. 2		gata1ahg2/+; gata1am651/+ ,   gata1ahg2/hg2 ,   gata1ahg2/+; gata1am651/+; la781Tg	nucleate erythrocyte absent, abnormal nucleate erythrocyte decreased amount, abnormal primitive hemopoiesis disrupted, abnormal
	Fig. 3		gata1am651/m651 ,   gata1ahg2/+; gata1am651/+	nucleate erythrocyte maturation disrupted, abnormal primitive hemopoiesis disrupted, abnormal
	Fig. 4		gata1am651/m651 ,   gata1ahg2/+; gata1am651/+	nucleate erythrocyte absent, abnormal nucleate erythrocyte present, abnormal whole organism dead, abnormal
	Fig. 5		gata1am651/m651 ,   gata1ahg2/+; gata1am651/+	macrophage differentiation increased occurrence, abnormal monocyte differentiation increased occurrence, abnormal primitive hemopoiesis disrupted, abnormal
Jin et al., 2009	Fig. 6		gata1am651/m651	primitive hemopoiesis process quality, abnormal
Vermot et al., 2009	Fig. 2		WT + MO1-gata1a	atrioventricular valve morphology, abnormal blood circulating cell absent, abnormal blood decreased viscosity, abnormal
Hall et al., 2007	Fig. S6		WT + MO1-gata1a	myeloid cell increased amount, abnormal
Phenotype Annotation (1994-2006)	Fig. for (m651)		gata1am651/m651 (AB)	anatomical system quality, abnormal blood decreased amount, abnormal
Weinstein et al., 1996	Fig. 3		gata1am651/m651 (AB)	heme biosynthetic process arrested, abnormal nucleate erythrocyte decreased amount, abnormal nucleate erythrocyte increased size, abnormal nucleate erythrocyte shape, abnormal